Page numbers printed in boldface type refer to tables or figures.
Absorption, and pharmacokinetics,442, 449
Academic functioning.
See Education; School(s)
Acceptance and commitment therapy (ACT),286
Accommodative coping,25
Acetaminophen,286, 290
Acute-onset illness,412
Acute pain,266.
See also Pain
Acute respiratory distress syndrome,224
Acute stress disorderanxiety symptoms and,209
definition of,213
differential diagnosis of depression and,173, 185
DSM-5 diagnostic criteria for,214–
216Adaptation, preparation for procedures and assessment of,492–493
Adherence, to treatmentassessment of,379,
380–
382consequences of nonadherence,372–373
developmental influences on,375–378
interventions for,379, 383–385
pretransplant psychiatric assessment and,327, 331
psychiatric factors in,378–379
rates of,371–372
risk factors for nonadherence,373–375
Adjustmentcancer patients and psychosocial,356–357
of family to chronic illness in child,31–32, 416–19,
420–
422organ transplantation and,336–337, 341–343
preparation for procedures and correlates of,492
Adjustment disorder,213, 219
Adjustment disorder with depressed mood,173, 184
Adolescentsconcepts of physical illness in,401–
402consent for treatment of as mature minors,77–78
correlates of adjustment to physical illness,27
developmental factors in pain,269–270
developmental understanding of death,364,
365family life cycle and,415informed consent and,74–75
prevalence of depression in,165
release of information and confidentiality,83–84
transition to adult health care by,13
treatment adherence and,373, 375–378
Adulthood, and correlates of adjustment to physical illness,27–28
Advocacy, and advocacy groupsfalse allegations of factitious disorder imposed on another and,318
role of consultant and,12–13
Affective lability, and delirium,101
Age.
See also Adolescents; Adulthood; Preschool children; School-age children
appropriateness of manifestations of grief and,367
of consent for sexual activity,85
Agitationcatatonia and,155
selection of medications for,458–459,
460–
469, 470–471
target symptom approach to psychopharmacology for,443treatment of as emergency,76, 77
AIE.
See Autoimmune encephalitis
Albumin binding, and pharmacokinetics,442, 444
Alcohol use.
See also Substance-related disorders
delirium and withdrawal from,122
pretransplant psychiatric assessment and,332
Alcohol Use Disorder Identification Test (AUDIT),117
Alexithymia,170, 235
Allergic symptoms, and factitious disorder imposed on another,309Alternate nostril breathing, and preparation for procedures,499–500
Amantadine, and neuroleptic malignant syndrome,142
American Academy of Child and Adolescent Psychiatry (AACAP),xii, xiii, 5, 45,
48–
52, 114, 255
American Academy of Pediatrics,75
American Board of Medical Specialties,361
American Board of Psychiatry and Neurology (ABPN),xii, 4
American Psychiatric Association,136
American Psychological Association,xii
Amitriptylinefor depression and anxiety,475insomnia and,482
pain and,287, 294
Amnesia, and delirium,99
Amphetamines,448,
457.
See also Stimulants
Analgesic medications, and delirium,103
Anesthesia, and preparation for procedures,497.
See also Hypnoanesthesia
Anger, and developmental concepts of illness,402–403
Antacids,448
Anterograde amnesia, and benzodiazepines,300
Anticholinergic medicationsdelirium and,103
gastrointestinal disease and,449
Anticholinergic syndrome, symptoms of,141Anticipatory bereavement,403–404, 425
Anticoagulant medications,453, 455
Anticonvulsants, and pain management,287,
295,
296–
298Antidepressants.
See also Tricyclic antidepressants
anxiety and,471, 477,
473–
474depression and,478
fatigue and,480
hepatic disease and,450pain management and,287, 291, 294
renal disease and,454respiratory disease and,458serotonin syndrome and,146Antiemetics, and serotonin syndrome,146Antiepileptics, and serotonin syndrome,146Anti–glutamic acid decarboxylase (GAD)–associated encephalitis,152, 153
Antihistamines, and agitation,471.
See also Diphenhydramine
Antihypertensives, and pain management,288Antimicrobialspediatric acute-onset neuropsychiatric syndrome and,159
serotonin syndrome and,146Anti-NMDA receptor encephalitis,137, 148, 150–151,
152Antipsychotics.
See also Haloperidol; Olanzapine; Risperidone
for agitation, aggression, irritability, or psychosis,459,
460–
466, 470
autoimmune encephalitis and,154
cardiac disease and,455,
456, 457
catatonia and,136–137
delirium and,114,
115hepatic disease and,450neuroleptic malignant syndrome and,137, 142–143
pain management and,288–
289, 300
renal disease and,454respiratory disease and,458Antisocial personality disorder,309
Anxiety, symptoms of.
See also Anxiety disorders
assessment of,226,
228cognitive-behavioral therapy and,394
co-occurrence of with depression in physically ill,171
correlates of adjustment to physical illness and,24, 29–30, 31
definition of,205
developmental concepts of illness and,402
direct physiological effects and,220–226
factitious disorder imposed on another and,311hypnosis and preparation for procedures,509
pain and relationship to,277
physical illness and risk of,206
physical signs of autonomic activity and psychological symptoms of,208–209
as psychological reaction to stress of illness,208–210,
211–
212, 212–213, 219–220
selection of medications for,471,
472–
476, 477
specific physical conditions and,221–226
target symptom approach to psychopharmacology for,443treatment of,226–227, 229
Anxiety disorder(s).
See also Anxiety; Generalized anxiety disorder; Illness anxiety disorder; Separation anxiety disorder; Social anxiety disorder; Substance/medication-induced anxiety disorder
antidepressants for,471
differential diagnosis of,207etiology of,206
prevalence of,206
primary types of in physically ill children,208Anxiety disorder due to another medical condition,220,
221Anxiolytic agents.
See also Benzodiazepines
cardiac disease and,456for depression and anxiety,475–
476hepatic disease and,451pain management and,288, 300
renal disease and,454respiratory disease and,458Apnea, and factitious disorder imposed on another,307,
308Approach-oriented coping,25
Aripiprazole,460, 470
Art, and psychotherapy,398
Asenapine,465Ask Suicide-Screening Questions (ASQ),197
Assent, and involvement of minors in treatment decisions,75
Assessment.
See also Diagnosis; Differential diagnosis; Standardized instruments
of anxiety,226,
228of autoimmune encephalitis,148
biopsychosocial formulation and,58–60
of catatonia,136
communication of findings from,60, 62–63, 66–67
critical steps in,36of delirium,105–112
of depression,195, 197,
198,
200–
201development of diagnosis and,58
of factitious disorder imposed on another,312–317
of family,431–433
goals of,35
of hypnotic responsivity,506
initial meeting with parents or caretakers and,39–40
interview with patient and,40–45
multiple sources of information for,37–38
of neuroleptic malignant syndrome,139
observation of behavior and play,56–58
organ transplantation and,325–333,
334of pain,272,
273–
275, 275–278,
279of parenting capacity and medical neglect,87–90
of pediatric acute-onset neuropsychiatric syndrome,157–158
preparation for procedures and,492–493
recommended questions for,68–71
responsive intake system and,36–37
role of consultant and,5, 9, 11–14, 37
screening instruments and,38
of serotonin syndrome,145
of somatic symptom and related disorders,247–249,
250–
252standardized principles for,45, 47,
48–
52of treatment adherence,379,
380–
382Associative logic,26
Asthma,224
Atomoxetine,451Attachment disorders, and factitious disorder imposed on another,310
Attending physician,6Attentiondelirium and,97, 99
distraction techniques and preparation for procedures,498
Attention deficit/hyperactivity disorder (ADHD),451, 483
Autism spectrum disorder,130, 459
Autoimmune disorders,131,
158Autoimmune encephalitis (AIE)assessment of,148
clinical presentation of,148
definition of,147–148
differential diagnosis of,148, 150–154,
158treatment of,154–155
Avoidance-oriented coping,25
Azathioprine,340Behavior.
See also Agitation; Behavioral interventions
assessment and observation of,56–58
autoimmune encephalitis and,151
concepts of illness and oppositional,403
depressive symptoms as regression in,184
grief and changes in,367
illness-maintaining and patterns of,425
of parents in factitious disorder imposed on another,310–311
Behavioral interventions.
See also Cognitive-behavioral therapy
for acute distress and anxiety in physical illness,29
for anxiety symptoms,227–229
for management of pain,280, 281–285
role of consultant and hospitalbased,12
for somatic symptoms and related disorders,257–258
for treatment adherence,384, 385
Belief system, of family,419.
See also Religion
Benzodiazepinesagitation and,155, 459, 470
anxiety and,226–227, 477
catatonia and,136, 155
delirium and,103, 114, 116, 122
hepatic disease and,451insomnia and,481
neuroleptic malignant syndrome and,142
pain management and,300
renal disease and,454respiratory disease and,457
serotonin syndrome and,145
Bereavement.
See also Grief
adjustment disorder with depressed mood and,184–185
death of child and anticipatory,403–404, 425
primary depressive disorder compared with,186psychotherapy and,399–400, 402–404
Bereavement rooms, in hospitals,363
Best-interest standard, for guardian decision making,74
Bilirubin, and psychotropic medications,448–449
Billing, and intake process,36–37.
See also Financial issues
Biofeedbackpain management and,282
preparation for procedures and,499
Biopsychosocial formulationassessment and development of,58–60, 66–67
of factitious disorder imposed on another,316, 317
of somatic symptom and related disorders,256
Bipolar disorders.
See also Mania; Substance/medication-induced bipolar and related disorder
differential diagnosis of depressive symptoms and,173, 174, 183–185
DSM-5 diagnostic criteria for,179–
183,
191–
192Body image, and chronic physical illness,330
Boston Children’s Hospital’s Transplant Experience Journal,333
Bouncing ball technique, and hypnosis,508
Boundary regulation, and family structure,420Brain tumors,349.
See also Cancer; Tumors
Breathing exercises, and preparation for procedures,499–500
Brief supportive therapy,399
Bromocriptine, and neuroleptic malignant syndrome,142
Bullying, and psychogenic nonepileptic seizures,235
Buprenorphine, and delirium,122
Bupropion,450,
473,
478, 480
Bush-Francis Catatonia Rating Scale,130
Buspirone,457, 477
Calcineurin inhibitors,338California Encephalitis Project,154
Cancer.
See also Five Ds; Psychosocial Standards of Care Project for Childhood Cancer; Tumors
anxiety symptoms and,221–223
family tasks associated with,358fatigue and,479
pain and,268
palliative care for,361–368
physical sequelae of,349, 355
psychosocial impact of,347–349
risk of suicide and,172
stem cell transplantation and,359–360
survival rates,347,
348, 359
types of childhood,348Cannabis-based medicines (CBMs),301
Capsaicin,300
Carbamazepinedrug-drug interactions and,447
hepatic disease and,451for pain,287,
296Cardiac disordersanxiety symptoms and,222, 223
direct effects of on brain,28
pretransplant psychiatric assessment and,330
psychopharmacology and,453, 455,
456–
457, 457
Cardiovascular complications, and organ transplantation,337
Case manager, role of in pediatric hospital setting,7Catatoniaagitation and,155
assessment of,130
clinical presentation of,128
delirium and,103–104
differential diagnosis of,129–130,
131–
132epidemiology of,128
high rates of mortality from,127
neuroleptic malignant syndrome and,131–
132, 138
pathophysiology of,128–129
risk of autoimmune encephalitis in patients with,155
treatment of,130, 136–137
Categorical approach, to physical illness,22–23
Causal comorbidity,9,
10, 11
Central nervous system disorderscatatonia and,131depressive disorders and,190
Centripetal and centrifugal forces, and family life cycle,416
Cerebrovascular conditions, and catatonia,131Challenge items, and hypnosis,504
Chaplain, role of in pediatric hospital setting,8Chemotherapy, adverse effects of,355, 360
Child abuse.
See also Medical neglect
factitious disorder imposed on another as variant of,306, 318
mandated reporting of,85, 318
parental access to information and,83
treatment adherence and patient history of,373
treatment of child without parental consent and,76, 79
Child life programs, and preparation for procedures,492–493
Child life specialist, role of in pediatric hospital setting,8Child protective service (CPS) agenciesfactitious disorder imposed on another and,313,
314, 316, 317, 318
medical neglect and,88
sources of information for assessment and,38
transfer of custody and termination of parental rights,89–90
Children.
See Adolescents; Child abuse; Development; Patient(s); Preschool children; School-age children
Children’s Depression Inventory, 2nd Edition (CDI-2),195
Children’s Global Assessment Scale,16
Children’s Hypnotic Susceptibility Scale,506
Children’s Oncology Group,347
Children’s Psychosomatic Checklist,249
Children’s Somatization Inventory,249
Chlordiazepoxide,122,
454Chlorpromazine,288, 300
Chronic-onset illness,412
Chronic pain,266.
See also Pain
Citalopram,456,
472Classification framework, and role of consultant in pediatric setting,9,
10, 11
Clinical consultation services, and practice patterns in pediatric CLP programs,15–16
Clinical Institute Withdrawal Assessment for Alcohol, Revised (CIWA-Ar),118–
119, 122
Clinical Manual of Pediatric Psychosomatic Medicine (Shaw and DeMaso 2006),xiii
Clinical Opiate Withdrawal Scale (COWS),120–
121, 122
Clonazepam,476Clonidine,483
Cloud-gazing technique, and hypnosis,507
Clozapine,456CLP.
See Pediatric consultation-liaison psychiatry
Codeine,286, 291, 301
Cognition, and cognitive impairment.
See also Memory
cancer and,355–356
common distortions of in patients with physical illness,395delirium and,99–100
organ transplantation and,343
pain and theories of,268–270
treatment adherence by adolescents and,377
Cognitive-behavioral therapy (CBT)for anxiety symptoms,226, 227
for depression in hospital,198
goals of in pediatric setting,394,
395for pain management,283–284
for somatic symptom and related disorders,258
Cognitive depression,170
Coincidental comorbidity,9,
10, 28
Collaborative care models, for pediatric CLP,4–5
Collaborative partnership, of family with pediatric team,429
Collateral contacts, and practice patterns in pediatric CLP,16
Co-located care, and models of collaborative care,4
Coma, and anti-NMDA receptor encephalitis,152Comfortpalliative care for cancer and,361
preparation for procedures and,492
Communication.
See also Language
of consultant with family on assessment,60, 62–63, 66–67
of family with pediatric team,430–431
family structure and problems with,422Comorbidity.
See also Psychiatric disorders
illness anxiety disorder and,247
pain and,277
pretransplant psychiatric assessment and,330
of psychiatric syndromes related to physical illness,9,
10unrelated psychiatric and physical illnesses occurring together,28
Complete-a-Sentence Exercise,45
Complex regional pain syndrome,267Concrete operations.
See School-age children
Concussion, and anxiety symptoms,225
Confidentialityfactitious disorder imposed on another and,316
as legal issue,82–86
Conflict, treatment adherence and parent-child,378–379
Congestive heart failure,453
Consent, for pediatric medical treatment,73–82, 317.
See also Informed consent
Constrained parental autonomy,74
Consultation-liaison psychiatry, as subspecialty,4.
See also Pediatric consultation-liaison psychiatry
Continuum, depression as,166
Contraception, and consent for treatment,78
Conversion disorder,240–
241, 242–244, 246
Coordinated care, and models of collaborative care,4
Coping Cat program,227
Coping, and coping methodsassessment of,55, 71, 492
coping skills training as intervention and,394, 496–500, 502
family adjustment to chronic illness and,419, 423,
424, 425
parenting capacity and,88
physical illness and style of,23,
24, 25–26
preparation for procedures and,492–493
somatization and,235–236
Cornell Assessment of Pediatric Delirium (CAPD),107,
110,
112Corticosteroids.
See also Steroids
changes in physical appearance and,378
dose-related impact of on mood lability and depression,342
organ transplantation and,336,
338, 378
Countertransference.
See also Therapeutic relationship
psychotherapy and,405–407
somatic symptom and related disorders and,252
CRAFFT Screening Questionnaire,117
Cranial radiation, and cancer,355
Cultureexpression of pain and,275
somatic symptom and related disorders and,237
Custody, of childconfidentiality and disputes about,86
termination of parental rights and transfer of,89–90
Cyclosporine,338–
339, 453
Cyclothymic disorder,173Cyproheptadine, and serotonin syndrome,145
Cystic fibrosis,224
Cytochrome P450 system, and drugdrug interactions,446, 447
DailyMed,484
Dantrolene, and neuroleptic malignant syndrome,142
Day treatment, for somatic symptom and related disorders,258
Death.
See also Mortality; Palliative care; Suicide
anticipatory bereavement and,403–404, 425
cancer and leading causes of,347
developmental understanding of,363–364,
365psychological sources of anxiety associated with physical illness,212Deferential partnership, of family with pediatric team,429
D-E-F Protocol,213
Deliriumassessment of,105–112
cancer and,349
clinical characteristics of,97–101
definition of,95
diagnostic criteria for,95–
97differential diagnosis of,103–105
epidemiology of,102
management of,113–122
organ transplantation and,334, 336
pathophysiology of,102–103
target symptom approach to pharmacology for,443use of terms for,97
Delusions, and factitious disorder imposed on another,311Denial, and grieving process,400, 402
Depression.
See also Depressive disorder due to another medical condition; Major depressive disorder; Major depressive episode; Persistent depressive disorder; Primary depressive disorder; Substance/medication-induced depressive disorder
assessment of,195, 197,
198,
200–
201cognitive-behavioral therapy for inflammatory bowel disease comorbid with,394
as continuum,166
developmental concepts of illness and,403
differential diagnosis of,172,
173, 174, 178–179, 183–184, 187, 190–192, 194–195,
199functional impairment and,171
health care behaviors and,171–172
misdiagnosis or underdiagnosis of,166, 170
morbidity and mortality of cooccurring physical illness and,172
overlap of symptoms of with physical illness,167–
169pain and,277
physical illnesses related to episodes of,188–
190prevalence of,165–166
selection of medications for,472–
476, 477–480
symptom perception and,170–171
target symptom approach to pharmacology for,443treatment adherence and,378
treatment of and interventions for,197–198
Depressive disorder due to another medical condition,186,
187, 190,
199Dermatologic symptoms, of factitious disorder imposed on another,308Deutsch, Felix,xi
Development.
See also Developmental disorders
concepts of physical illness and,401–
402correlates of adjustment to physical illness and,24, 26–28
factitious disorder imposed on another and relationship with parent,317
pediatric pain and,268–270
pretransplant psychiatric assessment and,329
treatment adherence and,375–378
understanding of death and,363–364,
365Developmental disorders.
See also Intellectual disability
acute agitation and,459
catatonia and,130
Dexmedetomidine,117
Dextroamphetamine,289, 300
Diagnosis.
See also Assessment; Differential diagnosis; DSM-5
of acute stress disorder,214–
216of anxiety disorder due to another medical condition,221of autoimmune encephalitis,151
of bipolar disorders,179–
183,
191–
192consultation requests and,9, 37,
61of conversion disorder,242–
243of depressive disorder due to another medical condition,187of factitious disorder imposed on another,305–306
of limbic encephalitis,153
of major depressive disorder,174–
176missed of depression in physically ill children,166, 170
of neuroleptic malignant syndrome,138,
139of persistent depressive disorder,176–
178of posttraumatic stress disorder,216–
219of somatic symptom disorder,238–
239of substance/medication-induced disorders,192,
192–
194, 194–195
Dialysis.
See Renal disease
Diaphragmatic breathing, and preparation for procedures,499
Diazepam,122, 468,
469Differential diagnosisof autoimmune encephalitis,148, 150–154
of catatonia,129–130,
131–
132of delirium,103–105
of depressive disorders,172,
173, 174, 178–179, 183–184, 187, 190–192, 194–195,
199of factitious disorder imposed on another,310–312
of neuroleptic malignant syndrome,131–
132, 138
of pediatric acute-onset neuropsychiatric syndrome,157,
158of psychogenic nonepileptic seizures and epilepsy,245of somatic symptom and related disorders,247,
248Diphenhydramine,468, 471, 480–481
Direct effects, of physical illness,22
Direct examination, and delirium,105
Disability, and adjustment of family to chronic illness,418
Disclosure of personal information, and psychotherapy,406
Disengagement, and coping responses to physical illness,25
Disorientation, and delirium,99
Disposition, as type of consultation request,9, 37,
62Disruptive mood dysregulation disorder,173, 183
Dissociation, and hypnosis,503
Distancing suggestions, and hypnosis,509
Distraction, and preparation for procedures,498
Distresscorrelates of adjustment in childhood physical illness and,24, 29–30
preparation for procedures and reduction of,492
Distress Thermometer,349
Divalproex,451Divorceauthorization to waive privilege and,87
custody disputes and issues of confidentiality,86
parental consent for treatment of child and,81–82, 84
“Doctor shopping,” and illness anxiety disorder,246
Dosages, of medications for patients with chronic illnesses,449, 452
Draw-a-Person Test,40–41
Droperidol,456, 470
Drug bioavailability, and absorption,442
Drug-drug interactions,144, 446–448
Drug-induced disorders, and catatonia,132.
See also Substance-related disorders
DSM-IV-TR, and factitious disorder by proxy,306
DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition)acute stress disorder in,214–
216anxiety disorder due to another medical condition in,221bipolar I disorder in,179–
183bipolar and related disorder due to another medical condition in,191–
192catatonia in,128,
129classification of psychiatric disorders and,xiii
conversion disorder in,242–
243definition of mental disorder in,58
delirium in,95–
97depressive disorder due to another medical condition in,187major depressive disorder in,174–
176overlap of symptoms of depression and physical illness,167–
169persistent depressive disorder in,176–
178posttraumatic stress disorder in,216–
219psychological factors in pain,266
somatic symptom disorder in,238–
239substance/medication-induced disorders and,192–
194Duloxetinefor anxiety,471,
474for depression,474pain management and,287, 295
Dysphoria, and grief,175
Dysthymia.
See Persistent depressive disorder
Eating disorders, treatment of as medical emergency,76
Education.
See also Learning; School(s)
assessment and initial meeting with parents,39
for family on delirium,114
family therapy and,432–433
for family on treatment adherence,383,
384group therapy and,395
on management of pain,281–282
on organ transplantation,333
of pediatric team by consultants,13–14
preparation for procedures and,493–495
Electrocardiographic monitoring, and tricyclic antidepressants,294
Electroconvulsive therapyfor catatonia,136
for neuroleptic malignant syndrome,142
Electroencephalogramsautoimmune encephalitis and,151
delirium and,101
Electronic medical records (EMRs),63
Electronic signature, and assessment report,67
Elimination, and pharmacokinetics,445
Emancipated minors, treatment of without parental consent,76–77
Emergencies, and treatment of child without parental consent,76,
77Emergency department, pharmacological treatment of agitation in,459, 470
EMLA,300, 497
Emotion(s).
See also Anger
adjustment after organ transplantation and,341–343
assessment of impact of physical illness on,53, 69
delirium and rapid fluctuations in,101
family reactions to chronic illness and,424–425
preparation for procedures and,492
Emotion-focused coping,25
Endocrine disordersanxiety symptoms and,222, 223–224
catatonia and,132episodes of depression and mania,188End-of-life strategies, and palliative care,361, 363–364
Enmeshment, and family structure,237,
420Environmental interventionsfor delirium,113–114
for depression in hospital,198
Epidemiology.
See also Prevalence
of catatonia,128
of delirium,102
of neuroleptic malignant syndrome,137
of pain,267–268
of pediatric acute-onset neuropsychiatric syndrome,156
of somatic symptom and related disorders,239,
240, 244, 246
Epilepsy.
See also Seizures
anxiety disorders and,225
differentiation of psychogenic nonepileptic seizures from,244,
245Escitalopram,456,
472, 478
Eszopiclone,481
Ethicsdisclosure of information and,84
factitious disorder imposed on another and,314Executive functions, and delirium,99
Experience journal, and preparation for procedures,496
Exposure, and preparation for procedures,496
Faces scale,271Factitious disorder imposed on another (FDIOA)assessment of,312–317
background of and diagnostic criteria for,305–306
clinical features of,306–310
differential diagnosis of,310–312
etiology of,310
legal issues and,317–318
treatment of,319–320
Factitious disorder imposed on self (FDIOS),305, 312, 316
False allegations, of factitious disorder imposed on another,318
Family.
See also Family meetings; Family therapy; Parent(s); Siblings
adjustment of to chronic illness of child,416–419,
420–
422assessment of effect of physical illness on functioning of,53–54, 70–71
beliefs of regarding pain,274–
275, 278
cancer in children and,357,
358communication of assessment findings to,60, 62–63, 66–67
correlates of adjustment in childhood physical illness and,24, 30–32
death of child and,364,
366education for on delirium,114
education for on management of pain,281–282
factitious disorder imposed on another and reunification of,320
illness course and,412–414
impact of chronic physical illness on functioning of,411, 423–425
life cycle of,414,
415, 416
organ transplantation and assessment of,326, 328–329, 330, 331–332
preparation of for assessment,38–39
somatic symptom and related disorders in,237
treatment adherence and,374, 375, 378–379, 382–383
working relationship of with pediatric team,429–431
Family-based integrated care,412
Family circle method,432
Family genogram,432
Family meetingscommunication of assessment findings and,60, 62
communication of family with pediatric team,430
factitious disorder imposed on another and,317–318
management of pain and,279management of somatic symptom and related disorders,252–253, 255
Family therapybenefits of,412
for factitious disorder imposed on another,320
guidelines for,431–436,
437for pain management,284
for somatic symptom and related disorders,258–259
for treatment adherence,384, 385
Family timeline,432
Fantasy, and preparation for procedures,500.
See also Rescue fantasies; Television fantasy
Fatigueoverlap of symptoms of depression and physical illness,168–
169selection of medications for,479–480
target symptom approach to psychopharmacology for,443FDIOA.
See Factitious disorder imposed on another
Fear, definition of,205
Feedback, and pretransplant psychiatric assessment,329
Feelings Mandala Project,41,
43, 398
Feelings Pie Project,41,
42, 398
Feeling Words Exercise,42, 44
Fentanyl,286, 291
Financial issues.
See also Billing
nonadherence with treatment and,372–373
payment for treatment as legal issue,82
service funding for pediatric CLP programs,17
Five Ds, and diagnosis of cancer,423
Fluoxetine,456,
472, 478
Food and Drug Administration (FDA),470, 484
Formal operations.
See Adolescents
Foster care, and transfer of custody,90
Full Scale IQ,355
Full-time faculty equivalents (FTEs),15
Functional Disability Inventory,249
Functional impairment, and depression,171
Funeral, discussion of with child,367–368
Gabapentininsomnia and,483
pain and,287, 295
renal disease and,454Gastrointestinal disorders.
See also Inflammatory bowel disease
anxiety symptoms and,233
factitious disorder imposed on another and symptoms of,307,
308posttransplant complications and,337
psychopharmacology and,449, 452
Generalized anxiety disorder,208Generalized Anxiety Disorder–7 (GAD-7),226
Genetic(s)anxiety disorders and,206
catatonia and disorders of,130
somatization and,235
Graft-vs.-host disease,360
Grief.
See also Bereavement
adjustment disorder with depressed mood and,184–185
major depressive episode distinguished from,175
primary depressive disorder compared to,186psychotherapy and process of,399–400, 402–404
responses of family to death of child,365,
366Group A beta-hemolytic streptococcal (GABHS) infections,156, 157, 159
Group therapygoals of in pediatric setting,395–396,
397siblings and,435
Guided imageryconsultant interventions and,12
for pain management,283
preparation for procedures and,500
Guidelinesfor family therapy,431–436,
437for integrated medical and psychiatric treatment of pain,279–
280for preparation for procedures,495standards of care for pediatric cancer patients and,350–
354Guilt, and countertransference,405
Hallucinations, and delirium,100
Haloperidolfor agitation, aggression, irritability, and psychosis,459,
466,
469, 470
cardiovascular side effects of,455,
456, 470
delirium and,115, 116, 122
pain management and,288, 300
Harm principle, and decision making by guardian,74
Hashimoto’s encephalopathy,153
Health care.
See also Hospitals; Integrated care; Laboratory tests; Medical history; Nurses; Physical examination; Physicians; Preparation for procedures
influence of depression on utilization and costs of,171–172
medical neglect and,88–89
pretransplant psychiatric assessment and previous experiences with,327Heart disease.
See Cardiac disorders
Heinroth, Johann,xi
Hematological symptoms, and factitious disorder imposed on another,308Hepatic disease, and psychopharmacology,448–449
Hepatic encephalopathy,330
Hierarchy, and family structure,421HIVpain and,268
risk of suicide in patients with,172
Homeless minors, treatment of without parental consent,76–77
Horizontal stressors, and family life cycle,414,
417Hormone-secreting tumors, and symptoms of anxiety,223–224
Hospitals, and hospitalization.
See also Emergency department; Health care; Intensive care unit; Partial hospitalization programs
assessment of child’s behavior in,56
behavioral regression in,184
bereavement rooms in,363
child life programs and preparation for procedures in,492–493
depression and environment of,198
financial support for pediatric CLP programs in,17
lawsuits against by victims of factitious disorder imposed on another,318
pretransplant psychiatric assessment and previous experiences with,327professional disciplines in,6–
8psychological sources of anxiety and,211recovery from organ transplantation and,335–336
as setting for psychotherapy,398–399
voluntary application for commitment to psychiatric,80
Hunter criteria, for serotonin syndrome,143,
145Hydroxyzine,300, 471,
476Hyperactive delirium,100, 105
Hyperarousal, and traumatic events,219
Hypersomnia, and depression,168.
See also Sleep disturbances
Hyperthermia, and neuroleptic malignant syndrome,138
Hyperthyroidism,225
Hypnoanesthesia,509
Hypomanic episodes, and bipolar I disorder,180–
181Hypnosisapplicability of in pediatric setting,394
for pain management,12, 283
preparation for procedures and,502–509
for procedural anxiety or pain management,12
for somatic symptom and related disorders,258
Hypnotic Induction Profile,506
Hypnotic Susceptibility Scale,506
Hypoactive delirium,100–101, 105
Hypochondriasis.
See Illness anxiety disorder
Hypoxia,224
Identified patient, concept of child as,60
Ideomotor techniques, and hypnosis,508
Illness anxiety disorder,240–
241, 246–247
Illness factors, and standardized principles for assessment,47
IMDH inhibitors,339–
340Imipramine,482
Immunomodulationautoimmune encephalitis and,154
catatonia and,137
pediatric acute-onset neuropsychiatric syndrome and,159
Immunosuppressive agents, and organ transplantation,336–337,
338–
341Indirect effects, of physical illness,22
Induction methods, for hypnosis,506–507
Infection, and infectious disorders catatonia and,131episodes of depression and mania,189factitious disorder imposed on another and,308treatment adherence and,372
Inflammatory bowel diseaseanxiety symptoms and,223
cognitive-behavioral therapy for,394
depression and,170
direct effects of on brain,28
Informationassessment and multiple sources of,37–38
preparation for procedures and content of,494
release of as legal issue,83–84
Informed consent.
See also Consent
definition of,74
living donors for organ transplantation and,333
third-party access to information and,84
Insight-oriented psychotherapy, for somatic symptom and related disorders,258
Insomnia.
See also Sleep disturbances
depression and,167–
168selection of medications for,480–483
target symptom approach to psychopharmacology for,443Insulin levels, and factitious disorder imposed on another,307
Intake system, setting up responsive,36
Integrated care.
See also Health care; Mental health care
family-based,412
models of collaborative care,4
organ transplantation and,323–324
treatment approach to pain,279–
280Intellectual disability, and legal limits of parental authority,80.
See also Developmental disorders
Intensive care unit (ICU), and delirium,98
International Association for the Study of Pain,265
Interview, with child or adolescent patient for assessment,40–45
Intravenous drug delivery, and bioavailability,442
I WATCH DEATH (mnemonic),103,
104Journals, on pediatric consultationliaison psychiatry,xii
Juvenile justice system, and sources of information for assessment,38
Kanner, Leo,xi
Kidney disease.
See Renal disease
Kinetic family drawing technique,398
La belle indifférence, and conversion disorder,243
Laboratory testsanxiety symptoms and,228autoimmune encephalitis and,149–
150,
151delirium and,105
depressive and manic symptoms,201factitious disorder imposed on another and alteration of,307
neuroleptic malignant syndrome and,139
pediatric acute-onset neuropsychiatric syndrome and,157–158
Lamotrigine,297,
451Language.
See also Communication
delirium and disturbances in,100
preparation for procedures and,494
Learning, and somatization,236–237.
See also Education; Social learning theory
Legal issues.
See also Mandated reporting; Safety
confidentiality and privilege as,82–87
consent for treatment as,73–82
factitious disorder imposed on another and,314, 317–318
limits of parental authority as,80–81
payment for treatment and,82
Letter writing, as intervention technique,398
Leukemia,349, 359
Level I Cross-Cutting Symptom Measures,38
Levetiracetam,298Liaison activities, of consultant with pediatric team,13–14
Lidocaine,300
Life cycle, of family,414,
415, 416
Limbic encephalitis (LE),151–153
Lithiumfor agitation, aggression, irritability, and psychosis,467cardiac disease and,456renal disease and,453,
454Liver, and drug metabolism,444, 445.
See also Hepatic disease; Hepatic encephalopathy
Living donors (LD), for organ transplantation,332–333,
334Long-term adjustment, of pediatric patients and families,30
Lorazepamagitation and,459,
468,
469, 470
catatonia and,136
for depression and anxiety,475–
476renal disease and,454Loss, and major depressive episode,182
Lurasidone,465Lyme disease,157, 159
Lymphoma,359
Magical thinking, in preschool children,26, 269, 364
Magic carpet technique, and hypnosis,508
Major depressive disorder,173,
174–
176Major depressive episode (MDE),175
181–
182Malingering, and factitious disorder imposed on another,311–312
Management.
See also Treatment
consultation requests and,9, 37,
61of delirium,113–122
of factitious disorder imposed on another,315–
316of pain,278–301
of somatic symptom and related disorders,240Mandated reporting, of child abuse,85, 318
Mania, and manic episodes.
See also Secondary mania
assessment of,200–
201bipolar I disorder and,179neurological causes of,191
physical illnesses related to,188–190
Mature minors, consent for treatment of,77–78
Meaning, of pain,276–277
Measurement, of pain,270–272
Medical family therapy,412
Medical history.
See also Medical records; Patient history
assessment of anxiety symptoms and,228assessment of delirium and,105
factitious disorder imposed on another and,313,
315pain and,276
Medical neglect.
See also Child abuse
assessment of parenting capacity and,87–90
somatic symptom and related disorders and,256
Medical records.
See also Medical history
assessment report and,63
factitious disorder imposed on another and falsification of,307
Medical severity, and correlates of adjustment to physical illness,24, 28
Medications.
See Pharmacology
Melatonin,117, 481–482
Membrane stabilizers, and pain management,287–
288Memoryaids for treatment adherence,383,
384delirium and,99
Mental health care.
See also Countertransference; Diagnosis; Integrated care; Management; Psychiatric disorders; Psychotherapy; Therapeutic relationship; Treatment;
specific disordersconsent for treatment and,79–80
pretransplant psychiatric assessment and history of,328psychiatric symptoms of autoimmune encephalitis and,154–155
Mental status examinationanxiety symptoms in pediatric setting and,228depressive and manic symptoms in pediatric setting and,200guidelines for assessment and,45, 66
Meperidine,286, 291
Metabolism, and metabolic disorderscatatonia and,132pharmacokinetics and,444–445
Methadone, and delirium,122
Methylphenidatecardiac function and,457pain management and,289, 299–300
Methylprednisolone,338Midazolam,468
Migraineepidemiology of,268
relaxation therapy for,283, 500
serotonin syndrome and medications for,146Mild depression,170
Mindfulness-based interventionsconsultant interventions and,12
goals of in pediatric setting,394–395
for pain management,284–285
Mirtazapine,474, 482
Mixed-type delirium,101
Modafinil,339, 480
Modeling, and preparation for procedures,495–496
Monitoring, degree of and adjustment of family to chronic illness,418
Monoamine oxidase inhibitors (MAOIs), and serotonin syndrome,144
Monoclonal antibodies,341Montreal Cognitive Assessment (MOCA),64–
65, 66
Mood and Feeling Questionnaire (MFQ),195
Mood scales,41,
44Mood stabilizersagitation and,471
cardiac disease and,456hepatic disease and,451renal disease and,454serotonin syndrome and,146Morphine,286, 291
Mortality, and mortality rates.
See also Death
cardiovascular side effects of psychotropic medications and,455
catatonia and,127, 129
depression and,172
factitious disorder imposed on another and,307
living donors for organ transplantation,333
neuroleptic malignant syndrome and,137
Motivations, of parents in factitious disorder imposed on another,311Motor symptoms, of conversion disorder,244
Movement imagery, and hypnosis,508
Munchausen by proxy (MBP),305–306
Muromonab-CD3 (OKT3),341Muscle tension, and pain,276
Mycophenolic acid,336
Narcissistic personality disorder,309
Narrative therapy,393, 436
National Cancer Institute,347
National Child Traumatic Stress Network (NCTSN),212–213
National Institute of Mental Health (NIMH),xi–xii, 156, 159, 478
National Sleep Foundation,482
Nephrotic syndrome,452
Neuralgia,267Neurocognitive disorders.
See Autoimmune encephalitis; Catatonia; Delirium; Neuroleptic malignant syndrome; Pediatric acute-onset neuropsychiatric syndrome; Serotonin syndrome
Neurodevelopmental assessment, and pretransplantation evaluation,329–330
Neuroleptic malignant syndrome (NMS)assessment of,139
autoimmune encephalitis in patients with,155
clinical presentation of,137–138,
141diagnostic criteria for,139differential diagnosis of,131–
132, 138
epidemiology of,137
pathophysiology of,138
risk factors for,140treatment of,141–143
Neurological disordersanxiety symptoms and,222delirium and,101
episodes of depression and mania in,188factitious disorder imposed on another and,308organ transplantation and,337
Neuropathic pain,267Neurotransmitters, delirium and dysregulation of,102–103
NMDA antagonists, and catatonia,136
NMS.
See Neuroleptic malignant syndrome
Noncategorical approach, to physical illness,23
Nociceptive pain,267Nonsteroidal anti-inflammatory drugs (NSAIDs),159,
286, 290
Normalization, of illness experience for family,433
Nortriptyline,455,
456Numeric rating scale,270,
271Nurses, and nursing.
See also Pediatric team
assessment of factitious disorder imposed on another and,314notes of as source of information for assessment,37
role of in pediatric hospital setting,6, 15
Nutritional disorders, and catatonia,131Nutritionists, role of in pediatric hospital setting,8Obsessive-compulsive disorder (OCD),156, 157
Occupation therapists, role of in pediatric hospital setting,8Olanzapinefor agitation, aggression, irritability, and psychosis,461,
469, 470
delirium and,115, 116
Omeprazole,447
Ophthalmic symptoms, of factitious disorder imposed on another,309Opioidsdelirium and,103, 114, 122
pain management and,286, 290–291,
292–
293serotonin syndrome and,147Organizational interventions, for treatment adherence,383, 385
Organ Procurement and Transplantation Network (OPTN),324
Organ transplantationdecisions on and preparation for,333–334
history and current status of,324
integrated behavioral health care and,323–324
listing for and waiting period,334–335
living donors and,332–333,
334posttransplant adjustment after,336–337, 341–343
pretransplant psychiatric assessment and,325–332
surgery for,335–336
survival rates after,324,
325treatment adherence following,372
Orthostatic hypotension, and tricyclic antidepressants,455
Ovarian teratoma, and autoimmune encephalitis,151
Over-the-counter medications, and serotonin syndrome,147Overprotectiveness, and family structure,420Oxazepam,454Oxcarbazepine,287Oxidative stress, and delirium,102
Oxycodone,286, 291
Pain, and pain managementanxiety and effective treatment of,229
cancer and,355
classification of,265–266,
267definition of,265
depression and perception of,170
developmental factors in,268–270
epidemiology of,267–268
hypnosis and,509
measurement of,270–272
preparation for procedures and management of,492, 497
principles of management,278–301
psychiatric assessment of,272,
273–
275, 275–278
psychotherapy and,406
risk of suicide and,172
target symptom approach to psychopharmacology for,444Pain-associated disability syndrome,280
Pain diary,272
Paliperidone,464Palliative care, and pediatric cancer,361–368
PANDAS.
See Pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections
Panic attacks,209,
210, 225
Panic disorder,206,
208, 224
PANS.
See Pediatric acute-onset neuropsychiatric syndrome
PANS/PANDAS Research Consortium,158–159
Parent(s).
See also Divorce; Family
access of to information on treatment,83–84
anxiety and distress during medical procedures,31
assessment of capacity for,87–89
consent for treatment of child,73–82
countertransference issues in psychotherapy and,405–406
death of child and,364
factitious disorder imposed on another and,310–311, 319
family therapy and establishing appropriate authority of,435
hypnosis and,504, 505–506
legal limits of authority,80–81
observation of play and,56–58
preparation for procedures and,494–495, 497
transfer of custody and termination of rights,89–90
treatment adherence and,376, 378–379
Parental Stressor Scale,54
Paroxetine,480
Partial hospitalization programs, for somatic symptom disorders,258
Passive coping,25, 26
Pathological lying, and factitious disorder imposed on another,309
Patient(s).
See also Patient history
assessment and initial meeting with,39
assessment and interview with child or adolescent,40–45
communication of assessment findings to,60, 62
concept of child as identified patient in biopsychosocial formulation,60
preparation of for assessment,38–39
privilege rules between physician and,86
Patient-controlled analgesia (PCA),291
Patient Health Questionnaire–9 (PHQ-9),195
Patient history.
See also Medical history
assessment report and,66
medical distress and long-term adaptation to physical illness,29–30
treatment adherence and,373,
374Pediatric acute-onset neuropsychiatric syndrome (PANS),155–159
Pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections (PANDAS),155, 156, 157, 159
Pediatric Catatonia Rating Scale,130,
133–
135Pediatric Confusion Assessment Method for the ICU Series,107,
110,
111Pediatric consultation-liaison psychiatry (CLP).
See also Assessment; Legal issues; Pain; Physical illness; Preparation for procedures; Psychiatric disorders; Referrals; Treatment
collaborative care models for pediatrics and,4–5
definition of,xi, 3
history and development of,xi–xii
organizations, journals, and textbooks on,xii–xiii
practice patterns in,14–17
roles of consultant in,5–14
use of terms for,3
Pediatric medical traumatic stress (PMTS),209–210, 212–213
Pediatric Preventive Psychosocial Health Model,349
Pediatric psychology,xii
Pediatric psychosomatic medicine.
See Pediatric consultation-liaison psychiatry
Pediatric team.
See also Nurses; Physicians
assessment of factitious disorder imposed on another and,314communication of assessment findings to,60, 62–63
liaison activities of consultant with,13–14
working relationship of family with,429–431
Pediatric ventricular assist devices (VADs),335
Peer group affiliation, and treatment adherence by adolescents,377–378
Perceptual disturbance, and delirium,100
Perpetuating factors, in biopsychosocial formulation,59
Persistent depressive disorder,173,
176–
178Personality traits.
See also Temperament
factitious disorder imposed on another and,309
response to pain and,277
somatization and,235
P-glycoproteins, and drug-drug interactions,447
Pharmacokinetics,442, 444–445
Pharmacology.
See also Antidepressants; Antipsychotics; Anxiolytic agents; Dosages; Drug-drug interactions; Medications; Opioids; Pharmacokinetics; Selective serotonin reuptake inhibitors; Side effects; Stimulants; Toxicity
anxiety as side effect of,222–223,
227, 228
cancer and,356–357, 360
for delirium,114,
115, 116–117
for depression,198, 201
medication selection and,457–459, 468, 470–471, 477–483
organ transplantation and,342–343
as potential causes of depression and mania,194–195,
196–
197psychiatric consultants and knowledge of,11–12
serotonin syndrome and,146–
147for somatic symptom and related disorders,259
specific physical illnesses and,448–457,
458target symptom approach to,441–442,
443–
444treatment interventions for pain and,274, 276, 285–301
Pheochromocytoma,223–224
Physical examination.
See also Laboratory tests
delirium and,101
depressive and manic symptoms in pediatric setting and,200factitious disorder imposed on another and,315Physical illness, in children.
See also Adherence; Cancer; Cardiac disorders; Endocrine disorders; Epilepsy; Gastrointestinal disorders; Neurological disorders; Organ transplantation; Pain; Preparation for procedures; Prognosis; Renal disease; Respiratory disease; Seizure(s)
anxiety symptoms in specific,221–226
categorical vs. noncategorical conceptualization of,22–23
children’s conceptions of,401–
402cognitive distortions and,395comorbidity of psychiatric syndromes with,9,
10, 11
correlates of adjustment to,23,
24, 25–32
definition of chronic,22
diagnostic categories benefiting from palliative care,362–
363differential diagnosis of somatic symptoms and,248impact of on family system and functioning,411, 423–425
overlap between symptoms of depression and,167–
169pretransplant psychiatric assessment and understanding of,327prevalence of,21
psychological sources of anxiety associated with,211–
212risk for symptoms of anxiety in,206, 208
somatization and past history of,237
somatopsychic illnesses and,11
treatment adherence and duration of,374, 375
types of related to episodes of depression and mania,188–
190Physical restraints, and delirium,113
Physical signs/symptoms, and factitious disorder imposed on another,308–
309Physical therapy, and physical therapistsfor management of pain,282
role of in pediatric hospital setting,8somatic symptom and related disorders and,257
Physicians.
See also Pediatric team
assessment of factitious disorder imposed on another,314assessment of patient relationship with,71
caregiver behavior and adjustment of child to physical illness,30
privilege rules between patient and,86
problem of burnout,14
role of in pediatric hospital setting,7somatic symptom and related disorders in primary care and,257
Plasmapheresis, and autoimmune encephalitis,154
Playassessment and observation of,56–58
preparation for procedures and,496, 498, 500
psychotherapy and,397–398
Positive reinforcementpreparation for procedures and,502
treatment adherence and,385
Positive statements, and preparation for procedures,497
Postconcussive syndrome,225
Posttransplant lymphoproliferative disorder (PTLD),337
Posttraumatic stress disorder (PTSD)definition of,213
delirium as risk factor for development of,98
depressive symptoms as psychological reaction to physical illness and,173differential diagnosis of depression and,185
DSM-5 diagnostic criteria for,216–
219pediatric medical traumatic stress and,209
treatment adherence and,378
Practice Parameter for the Psychiatric Assessment and Management of Physically Ill Children and Adolescents,45,
48–
52Predictability, and adjustment of family to chronic illness,418
Predisposing, precipitating, perpetuating, and protective factors (4 Ps), in biopsychosocial formulation,58–59
Prednisone,338Pregabalin,298Pregnancy, consent for prevention, treatment, or termination of,78
Prehypnotic interview,505
Preoperational phase.
See Preschool children
Preparation, for medical proceduresassessment of adaptation and coping,492–493
coping skills training and,496–500, 502
education and,493–495
effective forms of,491–492
exposure and,496
hypnosis and,502–509
modeling and,495–496
previous experience with hospitalization and,30
Preschool childrenconcepts of physical illness and,401correlates of adjustment to physical illness,26
developmental understanding of death by,364,
365family life cycle and,415pain and developmental factors,269
Preschool Confusion Assessment Method for the ICU (psCAMICU),107,
111Prevalence.
See also Epidemiology
of acute distress and anxiety in physical illness,29
of anxiety disorders,206, 225
of cancer-related fatigue,479
of catatonia,128
of delirium,102
of depression,165–166
of functionally impairing psychiatric disorders in children,9
of illness anxiety disorder,246
of physical illness in children,21
of posttraumatic stress symptoms,219–220
of somatic symptom disorder,239
of somatization,234
Primary control, and coping responses to physical illness,25, 26
Primary depressive disorder,174, 178–179,
186,
199Primary gain, and conversion disorder,243
Privilege, as legal issue,82, 86–87
Problematic partnership, of of family with pediatric team,429–430
Problem-focused coping,25
Prognosis, of physical illnessadjustment of family to chronic illness and,418–419
psychological sources of anxiety associated with,212Progressive illness,413
Progressive muscle relaxationpain management and,283
preparation for procedures and,499, 500,
501Propranolol,477
Protective factors, in biopsychosocial formulation,59
Protein binding, and psychopharmacology,442, 444, 449
PSCPCC.
See Psychosocial Standards of Care Project for Childhood Cancer
Psychiatric boarding,15, 17
Psychiatric disorders.
See also Anxiety disorders; Assessment; Bipolar disorders; Comorbidity; Delirium; Depression; Factitious disorder imposed on another; Mental health care; Neurocognitive disorders; Posttraumatic stress disorder; Psychosis; Somatic symptom and related disorders; Substance-related disorders; Treatment
catatonia in patients with,130
definition of in DSM-5,58
pretransplantation psychiatric assessment and,328prevalence of in children,9
Psychiatric factors, in treatment adherence,378–379
Psychodynamic psychotherapy,392–393, 396
Psychoeducation.
See Education
Psychogenic nonepileptic seizures,244,
245Psychological factorsanxiety associated with pediatric physical illness and,211–
212in biopsychosocial formulation,59
pain and,266, 276–278
somatic symptom and related disorders and,241Psychological factors affecting other medical conditions,185
Psychological reaction, depressive symptoms as,173, 184–185,
199Psychologists, on staff of hospitals,15
Psychomotor activitycatatonia and,128
delirium and,100
overlap of symptoms of depression and physical illness,169Psychosisanti-NMDA receptor encephalitis and,152factitious disorder imposed on another and,316
selected medications for agitation, aggression, and irritability, and,460–
467target symptom approach to psychopharmacology for,444Psychosocial adjustment, and cancer,356–357
Psychosocial Assessment Tool,349
Psychosocial interventions, for depression,198
Psychosocial Standards of Care Project for Childhood Cancer (PSCPCC),348–349,
350–
354, 356, 357, 360
Psychosocial team meeting, and assessment,63
Psychosomatic disorders, and physical symptoms caused by psychiatric illness,11
Psychosomatic medicine.
See Consultation-liaison psychiatry
Psychotherapy.
See also Psychodynamic psychotherapy; Supportive psychotherapy
for anxiety symptoms,227
cancer patients and,360
choice of approach to,396
countertransference issues for,405–407
for depression,477
duration and consistency of,399
for factitious disorder imposed on another,319–320
grieving process and,399–400, 402–404
hospital as setting for,398–399
models of,392–396
organ transplantation and,342
for pain management,284
pediatric acute-onset neuropsychiatric syndrome and,159
play and,397–398
research on effectiveness of,391–392
role of consultants in hospital setting and,12
for somatic symptom and related disorders,258–259
for treatment adherence,384, 385
Pulmonary disease, and anxiety symptoms,224
QT interval, and antipsychotics,455, 457, 470
Quality of lifepalliative care for cancer and,361
treatment adherence and,373
Quetiapine,116,
456,
462Radiation, and side effects of treatment for cancer,355, 360
Referralsassessment and,37, 60,
61–
62, 431–432
informing patient and family of reason for,38–39
reaction of family to,431–432
somatic symptom and related disorders and,247–248
types of requests for,9
Rehabilitation modelfor management of pain,280–281
for somatic symptom and related disorders,257–258
Reinforcement, of pain behaviors,275Relapsing/episodic illnesses,413
Relaxation therapyconsultant interventions and,12
for pain management,283
preparation for procedures and,498–499
Religionassessment of family and,55–56,
57, 419
medical neglect and,88
Renal diseasedialysis for and psychotropic medications,452, 453
dialysis for and risk of suicide,172
side effects of psychopharmacology and,452–453,
454symptoms of and factitious disorder imposed on another,308–
309Reports, writing of on assessment,63, 66–67.
See also Mandated reporting
Reproductive health, and consent for medical treatment,78
Rescue fantasies, and psychotherapy,405
Research, and role of consultant,14
Residents, and pediatric hospital,6Resistance, and family therapy,436
Respiratory disease.
See also Asthma; Pulmonary disease
side effects of psychopharmacology and,457,
458symptoms of and factitious disorder imposed on another,308Reversibility, and developmental concept of death,364
Richmond Agitation Sedation Scale (RASS),107,
110,
112Rigidity, and family structure,421Risk factorsfor delirium,102
for neuroleptic malignant syndrome,140for nonadherence with treatment,373,
374, 375
for suicide in dialysis patients,172
Risperidonefor agitation, aggression, irritability, and psychosis,463, 470
cardiac function and,456delirium and,115, 116
renal disease and,454Rituximab,337
Road Map of Life,44–45,
46Rockefeller Foundation,xi
Role allocation, and family structure,421Safetyof child in evaluation of factitious disorder imposed on another,318
health-related statutes on warnings about,85–86
School(s).
See also Education
assessment of impact of physical illness,55, 70
factitious disorder imposed on another and,307
organ transplant patients and,343
as source of information for assessment,38
School-age childrenconcepts of physical illness and,401correlates of adjustment to physical illness,27
developmental factors in pain,269
developmental understanding of death by,364,
365family life cycle and,415Screen for Child Anxiety Related Emotional Disorders (SCARED),226
Screening instruments.
See also Standardized instruments
assessment and,38
cancer patients and,349
for delirium,106–107
practice patterns in pediatric CLP programs and,16
Secondary coping responses, to physical illness,25, 27
Secondary gainpain and,278, 284
somatization and,236, 243
Secondary mania,183, 191
Seizure(s).
See also Epilepsy; Seizure disorders
autoimmune encephalitis and,151, 152, 153
conversion disorder and,244, 246
differentiating epilepsy from psychogenic nonepileptic,244,
245factitious disorder imposed on another and,307
somatization and,235
video-electroencephalographic monitoring of,249
Seizure disorders, and symptoms of anxiety,225
Selective mutism,208Selective serotonin reuptake inhibitors (SSRIs)anxiety and,226, 471,
472–
473cardiac disease and,456depression and,201,
472–
473gastrointestinal disease and,452
pain treatment and,294
renal disease and,453
serotonin syndrome and,144
Self-esteemchronic physical illnesses and,330
grief distinguished from major depressive episode and,175
Self-report measures, of pain,270,
271, 272
Sensorimotor stage.
See Preschool children
Sensory symptoms, of conversion disorder,244
Separation anxiety disorder,206,
208Separation-individuation, and treatment adherence by adolescents,376
Seronegative autoimmune encephalitis,154
Serotonin-norepinephrine reuptake inhibitors (SNRIs),226, 291, 295
Serotonin syndrome,141, 143–145,
146–
147Sertraline,473Service composition and demand, and practice patterns of pediatric CLP programs,15, 16–17
Sexual abuse, evaluation and treatment of without parental consent,79
Sexual activitydepression and loss of interest in,169exceptions to confidentiality and,85
Sexually transmitted diseases, and consent for treatment,78
Shared, family-centered decision making,74
Siblings.
See also Family
assessment of impact of physical illness on,54, 71
factitious disorder imposed on another and,307
family therapy and,435–436,
437pediatric cancer and,357
reactions of to chronic illness in family,425–426,
427–
428response to death of,364
Sickle cell disease,172, 300
Side effects, of medications.
See also Neuroleptic malignant syndrome; Serotonin syndrome
benzodiazepines and,477
cannabis-based medicines and,301
clonidine and,483
immunosuppressive agents and,338–
341opioids and,291,
292–
293psychostimulants and,480
psychotropic medications and cardiovascular,455
tricyclic antidepressants and,294
SIG E CAPS (mnemonic),195,
198Simulation, and preparation for procedures,496
Sirolimus,340Situational variables, and pediatric pain,276
Sleep disturbances.
See also Hypersomnia; Insomnia
delirium and,101
manic episodes and,191
pain and,276
Social anxiety disorder,206,
208Social factors, in biopsychosocial formulation,60
Social learning theorypreparation for procedures and,495
somatic symptoms and,237
Social relationships, assessment of impact of physical illness on,54–55, 70
Social service intervention, and somatic symptom and related disorders,256.
See also Child protective service agencies
Social support network, and pretransplant psychiatric assessment,331
Social workersassessment of factitious disorder imposed on another and,314role of in pediatric hospital setting,7, 15
Society of Pediatric Psychology,xii
Sociodemographic variables, in pain responses,272, 275
Socioeconomic status, and somatic symptom and related disorders,237
Somatic depression,170
Somatic Symptom Checklist,249
Somatic symptom disorder (SSD)clinical features of,238,
240–
241, 242
definition of,233
DSM-5 diagnostic criteria for,238–
239epidemiology of,239
factitious disorder imposed on another and,312
Somatic symptom and related disorders (SSRDs).
See also Conversion disorder; Illness anxiety disorder; Somatic symptom disorder; Somatization
assessment of,247–249,
250–
252classification of factitious disorders in DSM-5 and,305, 306
definition of,233
treatment of,249, 252–259
Somatization, risk factors for pediatric,234–237
Somatopsychic illnesses,11
Somatosensory amplification,236
Specific phobia,206,
208Spirituality.
See Religion
Sports activity technique, and hypnosis,508
Staff, communication of assessment findings to,62–63.
See also Nurses; Pediatric Team; Physicians
Staff-centered meetings, and assessment,63
Standardized instruments.
See also Screening instruments
for anxiety symptoms,226
for general assessment,45, 47
for somatic symptom and related disorders,249
Stanford Hypnotic Clinical Scale for Children,506
State custody, and limits of parental authority,80–81
Stem Cell Therapeutic Outcomes Database,359
Stem cell transplantation (SCT),359–360
Stepwise approach, for treatment of somatic symptom and related disorders,249,
254–
255Steroids,103, 154.
See also Corticosteroids
Stigma, and adjustment of family to chronic illness,418
Stimulants.
See also Dextroamphetamine; Methylphenidate
cardiac disease and,457depression and,201, 478–479
fatigue and,479–480
pain management and,299–300
Stress, and stressful life eventsfamily life cycle and,414,
417, 419
pain and,277
psychosocial in patients waiting for organ transplant,335
somatization and,235
Structural family approach, to family adaptation to chronic illness,419,
420–
422Substance Abuse and Mental Health Services Administration (SAMHSA),212
Substance/medication-induced anxiety disorder,225–226,
227Substance/medication-induced bipolar and related disorder,192,
193–
194, 194–195
Substance/medication-induced depressive disorder,192,
192–
193, 194–195
Substance-related disorders, and substance use.
See also Alcohol use; Withdrawal
catatonia and,132pretransplant psychiatric assessment and,328, 332
serotonin syndrome and,147treatment of without parental consent,79
Subsystems, and family structure,419
Suggestion method, and preparation for procedures,500
Suicide, and suicidalityadjustment disorder with depressed mood and,185
depression in physically ill patients and,172,
186factitious disorder imposed on another and,316
screening tool for risk of,197
treatment adherence in patients with depression and,378
Sundowning, and delirium,98
Supervision, and treatment adherence,384, 385
Supportive psychotherapyfor anxiety symptoms,227
choice of as psychotherapeutic approach,396
for depression in hospital,198
goals of in pediatric setting,392
Sydenham’s chorea,157
Symptom perception, and depression,170–171
Tacrolimus,336,
339Target symptom approach, to psychopharmacology,441–442,
443–
444Television fantasy, and hypnosis,507
Temperament, and correlates of adjustment in childhood physical illness,24, 29.
See also Personality traits
Temporal course, of delirium,98
Tension headaches,282
Tension-relaxation method, and preparation for procedures,500
Termination, of parental rights,89–90
Tetracaine,300
Texas Children’s Medication Algorithm Project,478
Textbook of Pediatric Psychosomatic Medicine (Shaw and DeMaso 2010),xiii
Textbooks, on pediatric consultationliaison psychiatry,xii–xiii
Therapeutic range, of drugs,444
Therapeutic relationship.
See also Countertransference
assessment interview and establishment of,40
factitious disorder imposed on another and,317
psychotherapy and,404, 405–406
Therapist monologue, and psychotherapy,398
Thinking, and thought.
See also Magical thinking
delirium and disturbances in,100
overlap between symptoms ofdepression and physical illness,169Third-party access, and release of information,84
Thyroid disease, and anxiety symptoms,225
Thyrotoxicosis,225
Tic disorders, and pediatric acute-onset neuropsychiatric syndrome,156,
158Topical anesthetics,300
Topiramate,296,
451,
454Toxicity, of medications catatonia and,132serotonin syndrome and,144
Toys, and preparation for procedures,498.
See also Play
Transcutaneous electrical nerve stimulation (TENS),283
Transformation, and preparation for procedures,498
Trauma-focused cognitive behavioral therapy, for anxiety symptoms,227
Trauma- and stressor-related disorders.
See Acute stress disorder; Adjustment disorder; Posttraumatic stress disorder
Traumatic brain injury,225
Trazodonecardiovascular side effects of,455
hepatic disease and,450insomnia and,482
respiratory disease and,457
serotonin syndrome and,144
Treatment.
See also Adherence; Behavioral interventions; Cognitive-behavioral therapy; Electroconvulsive therapy; Family therapy; Group therapy; Management; Pharmacology; Psychotherapy
of anxiety symptoms,226–227, 229
assessment and recommendations for,61–
62,
67of autoimmune encephalitis,154–155
of catatonia,130, 136–137
of depression,197–198
of factitious disorder imposed on another,319–320
for pain,274, 276
of pediatric acute-onset neuropsychiatric syndrome,158–159
role of consultant and,11–12
of serotonin syndrome,145
of somatic symptom and related disorders,249, 252–259
Treatment Recommendations for the Use of Antipsychotics for Aggressive Youth (TRAAY),470
Tremor, and delirium,101
Tricyclic antidepressants (TCAs).
See also Trazodone
for anxiety and depression,475cardiac disease and,455,
456clinical use at lower doses for pediatric patients,478
drug-drug interactions and,448
insomnia and,482
pain management and,291, 294
renal disease and,453
Tryptophan, and serotonin syndrome,144
Tumors, and episodes of depression and mania,189.
See also Brain tumors; Cancer
Understanding, assessment of in child and parent,53
United Network for Organ Sharing (UNOS),324
U.S. National Library of Medicine,484
Universality, and developmental concept of death,364
“Unspecified” diagnosis, as DSM-5 disorder category,58
Uridine glucuronosyltransferases (UGTs), and drug-drug interactions,446–447
Valproic acid,471
Vanderbilt Assessment for Delirium in Infants and Children,105,
108–
109Vapocoolant spray,300
Venlafaxineanxiety and,474depression and,478
pain management and,287, 295
renal disease and,454Verbal descriptor scale,270,
271Vertical stressors, and family life cycle,414,
417Video-electroencephalographic monitoring, of seizures,249
Video surveillance, and factitious disorder imposed on another,318
Virtual reality, and preparation for procedures,496
Visual analog scale,271, 272
Visual imagery techniques, and hypnosis,507–508
Visuospatial impairment, and delirium,100
Voltage-gated potassium channel (VGKC) antibody encephalitis,152
Waiver, of privilege,86–87
Weight loss or gain, and depression,167Withdrawal, from substance or alcohol use/abusedelirium and,117,
118–
121, 122
target symptom approach to psychopharmacology for,444Wolff-Parkinson-White syndrome,455
Working relationship, of family with pediatric team,429–431
Written consent, for treatment of child,74
Zaleplon,451, 481
Ziprasidone,470,
456, 483
Zolpidem,136,
451, 481
Zonisamide,298